Viewing Study NCT00016718


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2025-12-26 @ 3:55 AM
Study NCT ID: NCT00016718
Status: COMPLETED
Last Update Posted: 2021-11-05
First Post: 2001-05-31
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2001-08
Start Date Type: None
Primary Completion Date: 2009-01
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2001-05-31
First Submit QC Date: None
Study First Post Date: 2001-08-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-08-01
Results First Submit QC Date: None
Results First Post Date: 2017-10-17
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2010-01-22
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-11-03
Last Update Post Date: 2021-11-05
Last Update Post Date Type: ACTUAL